Histopathology of IgG4-Related Autoimmune Hepatitis and IgG4-Related Hepatopathy in IgG4-Related Disease

Abstract

Immunoglobulin G4-related disease (IgG4-RD) is a systemic disease involving many organs; it includes IgG4-related sclerosing cholangitis and inflammatory pseudotumor in the hepatobiliary system. Two types of hepatic parenchymal involvement have been reported in IgG4-RD: IgG4-related autoimmune hepatitis (AIH) and IgG4-hepatopathy. Moreover, only three cases of IgG4-related AIH have been reported. Immunoglobulin G4–related AIH is clinicopathologically similar to AIH, except for an elevated serum IgG4 level and heavy infiltration of IgG4-positive plasma cells in the liver tissue. Interestingly, IgG4-related AIH can be complicated by well-known IgG4-RD(s). Immunoglobulin G4-hepatopathy, which includes various histopathological lesions encountered in the liver of patients with type I autoimmune pancreatitis, is classified into five histological categories: portal inflammation, large bile duct damage, portal sclerosis, lobular hepatitis, and cholestasis. Immunoglobulin G4-hepatopathy is currently a collective term covering hepatic lesions primarily or secondarily related to IgG4-related sclerosing cholangitis and type 1 autoimmune pancreatitis. In conclusion, the liver is not immune to IgG4-RD, and at least two types of hepatic involvement in IgG4-RD have been reported: IgG4-related AIH and IgG4-hepatopathy. Additional studies are required to clarify their precise clinical significance with respect to IgG4-RD and inherent liver diseases.

Keywords

immunoglobulin G4-related disease - autoimmune hepatitis - immunoglobulin G4 hepatopathy - immunoglobulin G4-related autoimmune hepatitis - autoimmune pancreatitis

• References

• 1 Deshpande V, Zen Y, Chan JK , et al. Consensus statement on the pathology of IgG4-related disease. Mod Pathol 2012; 25 (9) 1181-1192
• 2 Stone JH, Chan JK, Deshpande V, Okazaki K, Umehara H, Zen Y. IgG4-related disease. Int J Rheumatol 2013; 2013: 532612
• 3 Zen Y, Harada K, Sasaki M , et al. IgG4-related sclerosing cholangitis with and without hepatic inflammatory pseudotumor, and sclerosing pancreatitis-associated sclerosing cholangitis: do they belong to a spectrum of sclerosing pancreatitis?. Am J Surg Pathol 2004; 28 (9) 1193-1203
• 4 Perricone G. Hepatic involvement in IgG4-related disease: IgG4-hepatopathy and IgG4-autoimmune hepatitis. Autoimmun Rev 2015; 14 (3) 268
• 5 Naitoh I, Zen Y, Nakazawa T , et al. Small bile duct involvement in IgG4-related sclerosing cholangitis: liver biopsy and cholangiography correlation. J Gastroenterol 2011; 46 (2) 269-276
• 6 Okazaki K, Yanagawa M, Mitsuyama T, Uchida K. Recent advances in the concept and pathogenesis of IgG4-related disease in the hepato-bilio-pancreatic system. Gut Liver 2014; 8 (5) 462-470
• 7 Zen Y, Fujii T, Sato Y, Masuda S, Nakanuma Y. Pathological classification of hepatic inflammatory pseudotumor with respect to IgG4-related disease. Mod Pathol 2007; 20 (8) 884-894
• 8 Nakanuma Y, Zen Y. Pathology and immunopathology of immunoglobulin G4-related sclerosing cholangitis: the latest addition to the sclerosing cholangitis family. Hepatol Res 2007; 37 (37) (Suppl. 03) S478-S486
• 9 Nakanuma Y, Tsuneyama K, Masuda S, Tomioka T. Hepatic inflammatory pseudotumor associated with chronic cholangitis: report of three cases. Hum Pathol 1994; 25 (1) 86-91
• 10 Umemura T, Zen Y, Hamano H , et al. IgG4 associated autoimmune hepatitis: a differential diagnosis for classical autoimmune hepatitis. Gut 2007; 56 (10) 1471-1472
• 11 Umemura T, Zen Y, Nakanuma Y, Kiyosawa K. Another cause of autoimmune hepatitis. Hepatology 2010; 52 (1) 389-390
• 12 Umemura T, Zen Y, Hamano H , et al. Clinical significance of immunoglobulin G4-associated autoimmune hepatitis. J Gastroenterol 2011; 46 (Suppl. 01) 48-55
• 13 Ishizu Y, Ishigami M, Kuzuya T , et al. Immunoglobulin G4-associated autoimmune hepatitis later complicated by autoimmune pancreatitis: a case report. Hepatol Res 2016; 46 (6) 601-606
• 14 Umemura T, Zen Y, Hamano H, Kawa S, Nakanuma Y, Kiyosawa K. Immunoglobin G4-hepatopathy: association of immunoglobin G4-bearing plasma cells in liver with autoimmune pancreatitis. Hepatology 2007; 46 (2) 463-471
• 15 Chung H, Watanabe T, Kudo M, Maenishi O, Wakatsuki Y, Chiba T. Identification and characterization of IgG4-associated autoimmune hepatitis. Liver Int 2010; 30 (2) 222-231
• 16 Kerkar N, Hadzić N, Davies ET , et al. De-novo autoimmune hepatitis after liver transplantation. Lancet 1998; 351 (9100) 409-413
• 17 Eguchi S, Takatsuki M, Hidaka M , et al. De novo autoimmune hepatitis after living donor liver transplantation is unlikely to be related to immunoglobulin subtype 4-related immune disease. J Gastroenterol Hepatol 2008; 23 (7 Pt 2): e165-e169
• 18 Castillo-Rama M, Sebagh M, Sasatomi E , et al. “Plasma cell hepatitis” in liver allografts: identification and characterization of an IgG4-rich cohort. Am J Transplant 2013; 13 (11) 2966-2977
• 19 Takemoto R, Miyake Y, Harada K , et al. Overlap of IgG4-related sclerosing cholangitis and primary biliary cirrhosis. Intern Med 2014; 53 (13) 1429-1433
• 20 Rosen D, Thung S, Sheflin-Findling S , et al. IgG4-sclerosing cholangitis in a pediatric patient. Semin Liver Dis 2015; 35 (1) 89-94
• 21 Alvarez F, Berg PA, Bianchi FB , et al. International Autoimmune Hepatitis Group Report: review of criteria for diagnosis of autoimmune hepatitis. J Hepatol 1999; 31 (5) 929-938
• 22 Okazaki K, Kawa S, Kamisawa T , et al; Working Committee of the Japan Pancreas Society and the Research Committee for Intractable Pancreatic Disease supported by the Ministry of Health, Labour and Welfare of Japan. Amendment of the Japanese Consensus Guidelines for Autoimmune Pancreatitis, 2013. I. Concept and diagnosis of autoimmune pancreatitis. J Gastroenterol 2014; 49 (4) 567-588
• 23 Okazaki K, Kawa S, Kamisawa T , et al; Research Committee of Intractable Diseases of the Pancreas. Clinical diagnostic criteria of autoimmune pancreatitis: revised proposal. J Gastroenterol 2006; 41 (7) 626-631
• 24 Maruyama M, Watanabe T, Kanai K , et al. Autoimmune pancreatitis can develop into chronic pancreatitis. Orphanet J Rare Dis 2014; 9: 77
• 25 Nakanuma Y. A novel approach to biliary tract pathology based on similarities to pancreatic counterparts: is the biliary tract an incomplete pancreas?. Pathol Int 2010; 60 (6) 419-429
• 26 Nakanuma Y, Harada K, Sasaki M, Sato Y. Proposal of a new disease concept “biliary diseases with pancreatic counterparts”. Anatomical and pathological bases. Histol Histopathol 2014; 29 (1) 1-10
• 27 Yeoman AD, Zen Y, Heneghan MA. IgG4 +ve autoimmune hepatitis is not observed among patients of non-Asian origin. Gut 2012; 61: A190
• 28 Anania C, De Luca E, De Castro G, Chiesa C, Pacifico L. Liver involvement in pediatric celiac disease. World J Gastroenterol 2015; 21 (19) 5813-5822
• 29 Schaffner F, Popper H. Nonspecific reactive hepatitis in aged and infirm people. Am J Dig Dis 1959; 4 (5) 389-399
• 30 Joshi D, Webster GJ. Letter: IgG4-hepatopathy and IgG4-associated autoimmune hepatitis—authors' reply. Aliment Pharmacol Ther 2015; 41 (3) 327
• 31 Harada K, Nakanuma Y. Pathological differences between IgG4-related sclerosing cholangitis with and without autoimmune pancreatitis. Mod Pathol 2013; 26: 403A
• 32 Hirano K, Shiratori Y, Komatsu Y , et al. Involvement of the biliary system in autoimmune pancreatitis: a follow-up study. Clin Gastroenterol Hepatol 2003; 1 (6) 453-464
• 33 Hamano H, Kawa S, Horiuchi A , et al. High serum IgG4 concentrations in patients with sclerosing pancreatitis. N Engl J Med 2001; 344 (10) 732-738
• 34 Uehara T, Hamano H, Kawa S, Sano K, Honda T, Ota H. Distinct clinicopathological entity ‘autoimmune pancreatitis-associated sclerosing cholangitis’. Pathol Int 2005; 55 (7) 405-411